Vedder Price

Vedder Thinking | Articles Deborah Lu Quoted in Bloomberg BNA Life Sciences Law & Industry Report


Vedder Price Shareholder Deborah Lu, Ph.D. was recently quoted in a Bloomberg BNA Life Sciences Law & Industry Report article entitled “Opinions Differ on Whether PTO Slides on Myriad Guidance Add Clarity.” The article discusses whether the new training slides, issued on March 19 by the U.S. Patent and Trademark Office as a result of the Myriad case, offer clarity or further complicate patent eligibility.

Dr. Lu opines that the slides do clarify the guidance. “They remind me of the Wands factors [referring to In re Wands, 858 F.2d 731 (Fed. Cir. 1988), which outlined an eight-factor analysis for determining whether biotechnology patent claims are enabled] and set forth the steps the PTO will follow for their analysis.”


Deborah L. Lu, Ph.D.